Federal Government Considers Changes to Newborn Screening Advisory Committee, Raising Concerns Over Condition Recommendations
The federal government is considering changes to its newborn screening advisory committee. The potential changes involve cutting the committee, which raises questions about the government’s understanding of the group’s purpose and signals a possible shift in policy. The advisory committee plays a crucial role in newborn screening programs. It advises the government on which conditions to screen for in newborns. This advice ensures early detection and treatment of potentially life-threatening diseases. Therefore, any changes to the committee’s structure or function could have significant implications for newborn health.
Newsflash | Powered by GeneOnline AI
Date: April 24, 2025
LATEST
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14